Pneumococcal pspA sequence types of prevalent multiresistant pneumococcal strains in the United States and of internationally disseminated clones

Citation
B. Beall et al., Pneumococcal pspA sequence types of prevalent multiresistant pneumococcal strains in the United States and of internationally disseminated clones, J CLIN MICR, 38(10), 2000, pp. 3663-3669
Citations number
28
Categorie Soggetti
Clinical Immunolgy & Infectious Disease",Microbiology
Journal title
JOURNAL OF CLINICAL MICROBIOLOGY
ISSN journal
00951137 → ACNP
Volume
38
Issue
10
Year of publication
2000
Pages
3663 - 3669
Database
ISI
SICI code
0095-1137(200010)38:10<3663:PPSTOP>2.0.ZU;2-I
Abstract
In a recent genotypic survey of beta-lactam-resistant pneumococci recovered in different areas of United States during 1997, eight clonal types that e ach represented 3 to 40 isolates accounted for 134 of 144 isolates (G. Gher ardi, C. Whitney, R. Facklam, and B. Beall, J. Infect. Dis. 181:216-229, 20 00), We determined the degree of pspA gene diversity among these 134 isolat es and for 11 previously characterized internationally disseminated multire sistant strains. Thirty-four different pspA restriction profiles were deter mined for an amplicon encompassing the variable portion of the structural g ene that encodes the surface-exposed domain of PspA and a variable-length p roline-rich putative cell wall-associated domain, These restriction profile s closely correlated with those of 33 different pspA sequence types of an a pproximately WO-residue region corresponding to residues 182 to 410 of the strain Rx1 PspA. These residues encompass a 100-residue clade-defining regi on known to contain cross-protective epitopes for which 17 sequence types w ere found. Distinct, conserved pspA sequence types were found for the major ity of strains within seven of the eight U.S. clonal types assessed, while one pulsed-field gel electrophoresis type was represented by isolates of th ree distinct PspA clades, Sequence typing of pspA provides an added level o f specificity in the subtyping of isolates and is a necessary first step in determining the components needed in a PspA vaccine which could elicit eff ective cross protective coverage.